Verition Fund Management operates as a multi-strategy and multi-manager investment platform.
Business Model:
Revenue: $0
Employees: 0-0
Address: 1 American Lane
City: Greenwich
State: CT
Zip: 06831
Country: US
Verition Fund Management operates as a multi-strategy and multi-manager investment platform. It has assembled a team of experienced, hard-to-access portfolio managers who draw their expertise from both proprietary trading desks and managing client accounts. The firm was founded in 2008 and is headquartered in
Contact Phone:
+12037427700
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2022 | Korro Bio | Series B | 0 |
9/2021 | LEXEO Therapeutics | Series B | 0 |
10/2021 | BYJU’S | Series F | 0 |
4/2021 | Biosplice Therapeutics | Venture Round | 0 |
4/2021 | GH Research | Series B | 125M |
5/2021 | Larimar Therapeutics | Post-IPO Equity | 0 |
7/2021 | Vedanta Biosciences | Series D | 0 |
9/2021 | Alebund Pharmaceuticals | Series B | 0 |
7/2020 | Praxis Precision Medicines | Series C | 0 |
6/2023 | Evommune | Series B | 0 |
7/2021 | Amylyx Pharmaceuticals | Series C | 0 |
4/2023 | Alebund Pharmaceuticals | Series C | 0 |
6/2023 | Evommune | Series B | 0 |
4/2023 | Alebund Pharmaceuticals | Series C | 0 |
1/2022 | Korro Bio | Series B | 0 |
10/2021 | BYJU’S | Series F | 0 |
9/2021 | Alebund Pharmaceuticals | Series B | 0 |
9/2021 | LEXEO Therapeutics | Series B | 0 |
7/2021 | Vedanta Biosciences | Series D | 0 |
7/2021 | Amylyx Pharmaceuticals | Series C | 0 |
5/2021 | Larimar Therapeutics | Post-IPO Equity | 0 |
4/2021 | Biosplice Therapeutics | Venture Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|